Considering that we further show that both IFNβ1 expression and the IFN signature identified in fibroblasts correlate with higher recurrence rates in BC, this paracrine signalling may be potentially targeted to improve the outcome of patients to CTX treatment. This evidence concerns the gene IFNB1 and breast cancer.